At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 87 enrolled
Drug / intervention
Normal saline +3 moredrug
Likely dose
Normal saline 10 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled Trial of Adding Intravenous Pantoprazole to Conventional Treatment for the Immediate Relief of Dyspeptic Pain
In Brief
A Phase 4 clinical trial evaluating Normal saline, Pantoprazole, and 2 other interventions for Dyspepsia and 2 related conditions. Completed, enrolled 87 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the immediate synergistic effect on the relief of severe acid-related dyspeptic pain by adding intravenous pantoprazole to the combination of oral antacid and antispasmodic agent (the conventional treatment).
Study Details
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedJan 2011
Primary CompletionOct 2011
TodayJul 2026
First PostedJan 24, 2011
Enrollment StartJan 1, 2011
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.4 years ago
Interventions
Normal salinedrug
10 ml of 0.9% sodium chloride solution
Pantoprazoledrug
80 mg of intravenous pantoprazole
Oral antaciddrug
30 ml of oral antacid (1.32 grams of aluminum hydroxide, 0.72 grams of magnesium hydroxide)
Hyoscine butylbromidedrug
20 mg of intravenous hyoscine butylbromide